THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY

The Lancet

Volumn 331, Issue 8579, 1988, Pages 197-203

  Simoons, M L ^a   Betriu, A ^a   Col, J ^a   Von Essen, R ^a   Lubsen, J ^a   Michel, P L ^a   Rutsch, W ^a   Schmidt, W ^a   Thery, C ^a   Vahanian, A ^a   Willems, G M ^a   Arnold, A E R ^a   De Bono, D P ^a   Dougherty, F C ^a   Lambertz, H ^a   Meier, B ^a   Raynaud, P ^a   Sanz, G A ^a   Serruys, P W ^a   Uebis, R ^a   Van De Werf, F ^a   Wood, D ^a   Verstraete, M ^a   European Cooperative Study Group, ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR;

CLINICAL TRIAL; CONTROLLED STUDY; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANGIOPLASTY, BALLOON; ASPIRIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMAN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; RECOMBINANT PROTEINS; RECURRENCE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0023830151     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)91062-8     Document Type: Article

References (21)

1. Improved survival after early thrombolysis in acute myocardial infarction: a randomized trial by the Interuniversity Cardiology Institute in the Netherlands
2. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study
3. Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction
4. Preservation of global and regional left ventricular function after early thrombolysis m acute myocardial infarction
5. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction
6. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction
7. Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction
8. A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction
9. Value of immediate coronary angioplasty following intracoronary thrombolysis in acute myocardial infarction
10. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator
11. Estimation of circulatory parameters in patients with acute myocardial infarction. Significance for calculation of enzymatic infarct size
12. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurements of serum alpha-hydroxybutyrate dehydrogenase levels
13. Thrombolysis m Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase
14. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
15. Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate
16. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion
17. Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial
18. Percutaneous transluminal coronary angioplasty after intracoronary steptokinase in evolving acute myocardial infarction
19. Percutaneous transluminal coronary angioplasty in evolving acute myocardial infarction
20. Morphology of the coronary arteries after combined thrombolysis and percutaneous transluminal coronary angioplasty for acute myocardial infarction
21. Status of the myocardium and infarct related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator) mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy